Molecule Details
| InChIKey | ZPUCINDJVBIVPJ-LJISPDSOSA-N |
|---|---|
| Compound Name | Cocaine |
| Canonical SMILES | COC(=O)[C@H]1[C@@H](OC(=O)c2ccccc2)C[C@@H]2CC[C@H]1N2C |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.95 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB00907 |
|---|---|
| Drug Name | Cocaine |
| CAS Number | 50-36-2 |
| Groups | approved illicit investigational |
| ATC Codes | S01HA01 S02DA02 N01BC01 R02AD03 |
| Description | An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of... |
Categories: Agents producing tachycardia Agents that reduce seizure threshold Alkaloids Analgesics and Anesthetics Anesthetics Anesthetics, Local Anticholinergic Agents Aza Compounds Azabicyclo Compounds Cardiovascular Agents Central Nervous System Agents Central Nervous System Stimulants Cholinesterase substrates Cocaine, antagonists & inhibitors Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Dopamine Agents Dopamine Uptake Inhibitors Esters of Benzoic Acid Highest Risk QTc-Prolonging Agents Local Anesthetics (Ester) Membrane Transport Modulators Muscarinic Antagonists Nervous System Neurotransmitter Agents Neurotransmitter Uptake Inhibitors OCT2 Inhibitors Ophthalmologicals QTc Prolonging Agents Sensory Organs Sensory System Agents Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Throat Preparations Tropanes Vasoconstrictor Agents
Cross-references: BindingDB: 86207 ChEBI: 27958 CHEMBL370805 ChemSpider: 10194104 Drugs Product Database (DPD): 20241 Guide to Pharmacology: 2286 IUPHAR: 2286 C01416 D00110 PDB: COC PharmGKB: PA449072 PubChem:446220 PubChem:46506326 RxCUI: 2653 Therapeutic Targets Database: DAP000834 Wikipedia: Cocaine ZINC: ZINC000003875336
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| Q12809 | KCNH2 | Homo sapiens | Human | PF00027 PF00520 PF13426 | 8.4 | IC50 | ChEMBL |
| Q01959 | SLC6A3 | Homo sapiens | Human | PF00209 | 6.5 | Ki | ChEMBL;BindingDB |
| P31645 | SLC6A4 | Homo sapiens | Human | PF03491 PF00209 | 6.5 | Ki | ChEMBL;BindingDB |
| P23975 | SLC6A2 | Homo sapiens | Human | PF00209 | 6.4 | IC50 | ChEMBL;BindingDB |
DrugBank Target Actions (16)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P02763 | P02763 | alpha1-acid glycoprotein | binder | carriers |
| P10632 | CYP2C8 | Cytochrome P450 2C8 | downregulator | enzymes |
| P10635 | CYP2D6 | Cytochrome P450 2D6 | inhibitor | enzymes |
| P06276 | BCHE | Cholinesterase | substrate | enzymes |
| P08684 | CYP3A4 | Cytochrome P450 3A4 | substrate | enzymes |
| P23141 | CES1 | Liver carboxylesterase 1 | substrate | enzymes |
| Q99720 | SIGMAR1 | Sigma non-opioid intracellular receptor 1 | agonist | targets |
| P08172 | CHRM2 | Muscarinic acetylcholine receptor M2 | antagonist | targets |
| P11229 | CHRM1 | Muscarinic acetylcholine receptor M1 | antagonist | targets |
| P23141 | CES1 | Liver carboxylesterase 1 | binder | targets |
| P23975 | SLC6A2 | Sodium-dependent noradrenaline transporter | inhibitor | targets |
| P31645 | SLC6A4 | Sodium-dependent serotonin transporter | inhibitor | targets |
| P35498 | SCN1A | Sodium channel protein | inhibitor | targets |
| Q01959 | SLC6A3 | Sodium-dependent dopamine transporter | inhibitor | targets |
| O15244 | SLC22A2 | Solute carrier family 22 member 2 | inhibitor | transporters |
| Q01959 | SLC6A3 | Sodium-dependent dopamine transporter | inhibitor | transporters |